INTRODUCTION
Space flight or simulated microgravity (head-down-tilt bed rest) leads to a reduction in plasma volume (2, 3, 5, 9, 14, 15) and apparent changes in baroreflex function (5, (7) (8) (9) (10) (12) (13) (14) (15) (16) 24, 29) . Despite extensive study of cardiovascular reflex control after spaceflight or bed rest, it is unclear whether the observed changes in baroreflex function after bed rest are due to hypovolemia alone, or represent a unique adaptation of the autonomic nervous system to bed rest deconditioning. In a previous study (15) , we demonstrated in the same subjects that both chronic (2 weeks) head-down-tilt bed rest and acute hypovolemia matched for loss of plasma volume, led to similar reductions in transfer function gain between blood pressure and R-R interval. This similarity of the response under both conditions in the same subjects suggested, but did not prove, that a reduction in plasma volume may be largely responsible for the abnormality of baroreflex regulation of cardiac period after bed rest. In the present study, we hypothesized that this reduced spontaneous baroreflex sensitivity after bed rest could be normalized to the pre-bedrest level by precise plasma volume restoration with intravenous volume infusion. To test this hypothesis directly, we quantified dynamic baroreflex sensitivity by using transfer function analysis between spontaneous changes in arterial pressure and R-R interval before and after 2 weeks of head-down-tilt bed rest, and after precise plasma volume restoration by Dextran infusion which normalized both plasma volume and cardiac filling pressures.
METHODS

Subjects
Five healthy men and one woman with a mean age of 38±8 (± SD) years old (range; 28-49 years), height of 181±4cm, and body weight of 80±15kg were studied. No subject smoked, used recreational drugs, or had significant chronic medical problems. No subject was an endurance trained athlete, and subjects were excluded if they exercised for more than 30min/day, more than 3 times per week with either dynamic or static exercise. Subjects were screened with a careful history and physical examination including ECG and echocardiogram. All subjects signed an informed consent approved by the Institutional Review Boards of the University of Texas Southwestern Medical Center at Dallas and Presbyterian Hospital of Dallas.
Experimental protocol
All experiments were performed in the supine position, in the morning, at least 2 hours after a light breakfast and more than 12 hours after the last caffeinated beverage or alcohol, in a quiet, environmentally controlled laboratory with an ambient temperature of 25 º C. A 6F balloon tipped, flow-directed pulmonary arterial catheter (Edwards Swan-Ganz, Baxter) was placed under fluoroscopic guidance through an antecubital vein into the pulmonary artery. With the balloon inflated, the catheter was advanced into the pulmonary capillary wedge position, which was confirmed fluoroscopically and by the presence of characteristic pressure waveforms. Right atrial pressure (RAP) and pulmonary capillary wedge pressure (PCWP) were referenced to atmospheric pressure, with the pressure transducer (Transpac IV, Abbott) zero reading set at 5cm below the sternal angle in the supine position. The pressure waveform was amplified (Hewlett-Packard 78534A and Astromed ASC909) and displayed on a strip-chart recorder (Astromed MT 95000) with 0.5mmHg resolution. The mean PCWP was determined at end expiration.
An analog ECG was obtained from a CM 5 lead, and beat-by-beat arterial blood pressure was obtained at the finger by photoplethysmography using the Penaz principle (Finapres,Ohmeda).
Intermittent blood pressure was measured in the arm by electrosphygmomanometry (Suntech) with a microphone placed over the brachial artery and the detection of Korotkoff sounds gated to the ECG. Cardiac output was measured with a modification of the foreign gas rebreathing method using acetylene as the soluble and helium as the insoluble gas (25, 33 ). Resting stroke volume was then calculated from heart rate measured via ECG at the same time.
Following establishment of quiet, resting, hemodynamic steady state (usually ~30 min of repeated measurements until sequential cardiac output measurements within 500ml), arterial blood pressure and ECG were recorded during 6 min of spontaneous respiration. Following spontaneous respiration, the subjects were asked to control their respiratory frequency at a fixed rate of 12/min (0.20Hz) by following a controlled breath graph on a laptop computer mounted above the subject's face. After a 2 min adjustment period of breathing control, 6 min of data were recorded again. The data from the fixed breathing protocol were used to concentrate the spectral input around the respiratory rate for the spectral analysis and to verify the results of transfer function analysis during the spontaneous breathing protocol. After this data collection period, plasma volume was measured using the Evans blue dye technique (11).
Head-down-tilt bed rest (simulated microgravity) Following the initial baseline experiments (pre-bedrest experiments), the subjects were placed at complete bed rest with -6° head-down-tilt. Subjects were allowed to elevate up on one elbow for meals, but otherwise were restricted to the head down position at all times. Subjects were given a standard diet three days before each testing session both before and after bed rest, consisting of fixed calorie and sodium contents (2,500 Kcal, 3.5 gm). Fluids were allowed ad libitum, but all fluid intake and urine output were carefully recorded. The same experiments (post-bedrest experiments) were repeated after 2 weeks of head-down-tilt bed rest.
Volume restoration
After post-bedrest experiments, both plasma volume and left ventricular end-diastolic pressure were restored to pre-bedrest levels by Dextran 40 infusion as follows. First, the exact amount of plasma lost during bed rest was quantified by Evans blue dye. This volume was infused rapidly (~1000ml/hr), and then allowed to equilibrate for 30 minutes. If pulmonary capillary wedge pressure was still below baseline pre-bedrest values, additional Dextran was infused in 100-250ml increments until baseline pulmonary capillary wedge pressure was achieved.
Hemodynamic measurements (cardiac output, stroke volume, HR, BP) were initiated 30 minutes following completion of the last Dextran infusion and repeated until stable as described above, which generally required an additional 30 minutes. Data collections periods for spontaneous and controlled breathing were then repeated, approximately 1 hour after completion of Dextran infusion.
Spectral and Transfer function analysis
The analog ECG and arterial pressure were analyzed as previously reported (15) . High frequency power of R-R interval and SBP in the range of 0.15~0.25Hz and low frequency power in the range of 0.05~0.15 Hz were calculated from the integration of the autospectra during the fixed breathing protocol. These values were also divided by the total spectral power to minimize the effect of the changes in total power on the values of low and high frequency components. This approach derives normalized spectral indexes. This data acquisition and processing strategy conforms to recommendations of international consensus panels for the assessment of cardiovascular variability (30) .
The transfer function gain, phase, and coherence (the squared coherence function) between SBP and R-R interval (or heart rate) were estimated using the cross spectral method (9, 15, 22, 27, 28) (Fig. 1) . Transfer function gain, phase and coherence between SBP variability and R-R interval (or heart rate) variability were estimated as mean values in the high frequency range (0.15~0.35Hz for the data from the spontaneous breathing protocol; 0.15~0.25Hz for the data from the fixed breathing protocol) and in the low frequency range (0.05~0.15 Hz). These frequency ranges were chosen, because of the high coherence function. The transfer function gain between rhythmic changes in the SBP and R-R interval was used to reflect baroreflex function, while the estimated phase was used to reflect the temporal relationship between these two variables (9,28).
The assumption of linearity and reliability of the transfer function estimation was evaluated by the coherence, which ranges between 0 and 1.
In addition, the calculated gain for heart rate (in beats per min/mmHg) was multiplied by the resting stroke volume to determine the effective change in systemic flow (i.e., cardiac output) induced by baroreflex mediated changes in heart rate, or the "effective gain" of the baroreflex regulation of heart rate (18).
The range of baroreflex stimuli and baroreflex response
The global range of the baroreflex stimulus was estimated by the range in SBP variation and the standard deviation of SBP variation. The global range of baroreflex response was estimated by the range in R-R interval and standard deviation of R-R interval variation.
Statistical Analysis
Variables were compared using one-way repeated-measures analysis of variance (ANOVA) with time (Pre-bedrest, Post-bedrest, and Post-Dextran), in conjunction with the Dunnet post hoc test for comparisons with pre-bedrest values. A p value <0.05 was considered statistically significant. The analysis was performed using a PC-based software (ABstat, Anderson Bell). Data are presented as mean ± standard error.
RESULTS
Plasma volume and Dextran infusion
Plasma volume significantly decreased after bed rest (3190±120ml to 2920±90ml, p<0.05).
Associated with this change, pulmonary capillary wedge pressure and right atrial pressure significantly decreased after bed rest (p<0.05) ( Table 1 ). 288±31 ml of Dextran 40 were used to restore both plasma volume and cardiac filling pressures to pre-bedrest levels ( Table 1) .
Hemodynamic variables
Hemodynamic data after head-down bed rest and Dextran infusion are listed in Table 1 . Heart rate significantly increased after bedrest. However, it returned to near pre-bedrest levels after Dextran infusion. Neither systolic blood pressure nor diastolic blood pressure changed significantly. Stroke volume and cardiac output significantly decreased after bedrest. However, they returned to near or above pre-bedrest levels after Dextran infusion.
Spectral analysis
Spectral power data are listed in Table 2 . The high frequency power of R-R interval variability and the normalized high frequency power tended to decrease after bed rest consistent with vagal withdrawal (p=0.10, p=0.08, respectively). However, the low frequency power of R-R interval variability did not change. Associated with these changes, the ratio of low to high 8 frequency power significantly increased after bedrest (p<0.05). It returned to the pre-bedrest level after Dextran infusion. Neither low frequency power of systolic blood pressure variability nor high frequency power of systolic blood pressure variability changed significantly.
Transfer function analysis of baroreflex function
High frequency transfer function gain expressed as R-R interval, used as an index of vagally mediated arterial-cardiac baroreflex function, significantly decreased after bed rest (p<0.05).
However, this reduced transfer function gain was normalized to the pre-bedrest level after plasma volume restoration (Fig.2) (Table 3 ). In contrast, as noted previously (15), transfer function gain expressed as heart rate did not decrease significantly after bed rest during the fixed breathing protocol (p=0.2) (Table 3) . However, when the gain in terms of heart rate was multiplied by the resting stroke volume to determine the effective change in systemic flow induced by baroreflex mediated changes in heart rate, there was virtually the same change in "effective gain" compared with that observed with R-R interval (p<0.05) ( Table 3) .
Low frequency transfer function gain did not change significantly (Table 2) , although the gain expressed as R-R interval tended to decrease after bed rest during the spontaneous breathing protocol (p=0.12) (Fig.2) . It was also normalized to the pre-bedrest level after plasma volume restoration (Fig.2) .
Estimation of coherence function was above 0.5 in both high and low frequency range under all conditions: 0.57±0.04 in the high frequency range, and 0.54±0.03 in the low frequency range during the spontaneous breathing protocol; 0.67±0.04 in the high frequency range, and 0.55±0.04 in the low frequency range during the fixed breathing protocol. A negative phase between the 9 systolic blood pressure and the R-R interval, and a positive phase between the systolic blood pressure and the heart rate were observed in all cases, and these phases did not change.
The range of baroreflex stimuli and baroreflex response (Table 4) The range in SBP variation and the standard deviation of SBP variation as the global range of baroreflex stimuli during spontaneous breathing increased after bed rest, and then returned to pre-bedrest levels after Dextran infusion. Conversely, the range in R-R interval and SD of R-R interval variation as the global range of baroreflex response decreased after bed rest, and then returned to pre-bedrest levels after Dextran infusion.
DISCUSSION
These results extend and confirm our previous report that showed significant reductions in the transfer function gain between blood pressure and R-R interval or blood pressure and HRxSV after head-down-tilt bed rest or induced hypovolemia (15) . The fact that these reduced transfer function baroreflex gains were normalized to the pre-bedrest levels by plasma volume restoration, demonstrates convincingly that reductions in plasma volume, rather than a unique autonomic nervous system adaptation to bed rest, are largely responsible for the observed changes in dynamic arterial-cardiac baroreflex control around the operating point after bed rest.
Baroreflex control and plasma volume
There is much literature regarding the effect of space flight or microgravity simulation on reflex control of the circulation. The carotid-cardiac baroreflex (5, 8, 10, 12, 13) , and the spontaneous arterial-cardiac baroreflex function estimated by either transfer function (7, 9, 15, 16) or by sequence analysis (14, 16, 24, 29) may be impaired after spaceflight or bed rest, and is associated with a reduction in plasma volume (2, 3, 5, 9, 14, 15) . Decreases in spontaneous arterial-cardiac baroreflex indexes after space flight or microgravity simulation are consistent with most reports that measured these indexes during acute interventions such as head-up-tilt (24, 34) or LBNP (9, 14, 17, 24) . Thus it seems that a common feature of central hypovolemia is a reduction in spontaneous arterial-cardiac baroreflex function estimated by transfer function analysis and/or sequence techniques.
A reasonable interpretation of these data is that the reduction in spontaneous arterial-cardiac baroreflex function is due to a reduction in plasma volume and/or central hypovolemia. However one previous report using a neck chamber technique showed that the time course of changes in blood volume and the carotid-cardiac baroreflex were not parallel during bed rest (5). These investigators argued that the reduction in blood volume therefore may not be the sole cause of carotid-cardiac baroreflex abnormalities after bed rest. In fact, the carotid-cardiac baroreflex as assessed by a neck chamber technique may not be altered at all by hypovolemia (31) . Moreover, one additional report showed that arterial-cardiac baroreflex function estimated by infusion of phenylephrine also did not decrease after bedrest (8) , and there are similar reports that global-cardiac baroreflex function estimated by steady-state phenylephrine infusion (6) or the Valsalva maneuver (21) did not decrease after hypovolemia. These differences in the methods of assessing the baroreflex may reconcile these apparently contradictory results. For example, central hypovolemia reduces stroke volume and pulse pressure and these reductions increase heat rate via baroreflex mediated sympathetic activation and vagal withdrawal. Combined, these alterations in neural input appear to reposition the operating point on the static stimulus-response curve of the baroreflex, closer to the threshold of baroreflex activation (12) . As a consequence of this shift, further decreases in arterial pressure are met with a smaller degree of baroreflex unloading than when the operating point is positioned closer to its maximal gain. However when hypertension is induced by phenylephrine, the baroreflex is fully capable of being stimulated normally, and may respond with normal (carotid), or even enhanced (aortic) increases in vagal outflow. Similarly, if the operating point has moved closer to threshold, there will be little additional baroreflex unloading during neck pressure which is the initial part of the neck collar protocol used by previous investigators (5, 10) . However during the potent neck suction that follows, the baroreflex may still be stimulated normally, resulting in no change in maximal gain calculated by this technique. Thus, even if the static curve of the baroreflex does not change at all, spontaneous baroreflex function, which is heavily influenced by the slope of baroreflex curve around its operating point may still change.
This difference in interpretation of how the baroreflex changes with bedrest and/or hypovolemia depending on the technique used to assess baroreflex function may have important physiological significance as well. For example, since bedrest induces orthostatic hypotension, rather than hypertension, how the baroreflex functions during decreases in arterial pressure associated with hypovolemia would seem to be more clinically relevant than how it responds to induced hypertension. If the reserve of the baroreflex to augment heart rate in response to upright posture is diminished, theoretically at least, blood pressure control could be compromised even if the response to hypertension remained intact. It is important to note however that in this and virtually all bed rest and spaceflight studies (2) (3) (4) 9, 12, 13, 20, 24, 29) , the apparent abnormalities of baroreflex control of heart rate are not sufficient to impair the heart rate response to the upright posture, and do not likely play a major role in the etiology of orthostatic hypotension under these conditions.
A few other methodological considerations should be addressed. First, as noted above, transfer function analysis of spontaneous variations between blood pressure and R-R interval has been employed by many investigators for the evaluation of dynamic properties of baroreflex function around the operating point (1, 22, 26, 27, 28) . Under normal conditions, this transfer function gain correlates significantly with other measures of cardiac-baroreflex function including vasoactive drug methods and sequence analysis (17, 22, 26, 27) . Therefore, we and others have considered that this technique is a useful and convenient tool for the assessment of dynamic cardiac-baroreflex function emphasizing the frequency dependence of R-R interval and blood pressure control. However, there are arguments over its limitations, and/or interpretation as discussed previously (15) . For example, the coherence function needs to be above 0.5 to guarantee a fundamental assumption of linearity between changes in arterial pressure and cardiac period (27, 28) . In the present study, the coherence function was sufficiently high in both frequency ranges, confirming the validity of using this technique for the assessment of gain and phase.
Furthermore, the phase between the systolic blood pressure and the R-R interval was always negative in all cases, minimizing the concern with the feed-forward effects of heart rate on systolic blood pressure (1, 15) .
The other problem with estimating the arterial-cardiac baroreflex function is whether to express the sensitivity by HR units (beats/min) or R-R interval (msec). However, regardless of whether transfer function gain was expressed as HR units (multiplied x SV) or R-R interval, we observed decreases in baroreflex control, and these results are exactly the same as those we have reported previously (15) . Therefore, the premise of this study is that the technique of transfer function analysis between blood pressure and R-R interval is a reliable tool for the assessment of spontaneous arterial-cardiac baroreflex function around the operating point after bed rest and/or hypovolemia.
Perspectives (orthostatic intolerance and the baroreflex)
In a previous study (15) , we sought to determine whether the reduction in spontaneous arterial-cardiac baroreflex function could be due to a reduction in plasma volume. To address this question, the effect of head-down-tilt bed rest (chronic hypovolemia plus "deconditioning") was compared to acute hypovolemia without bed rest "deconditioning" in the same subjects. We found that transfer function gain in the high frequency range decreased similarly after both head-down-tilt bed rest and acute hypovolemia. Therefore, we concluded that reduced arterial-cardiac baroreflex function in this frequency range after head-down-tilt bed rest was likely due primarily to a reduction in plasma volume associated with head-down-tilt bed rest. However, the evidence was not dispositive, and was dependent on inference rather than correction of the changes in dynamic baroreflex control with normalization of plasma volume. Despite the clearly reduced spontaneous baroreflex gain after bedrest in this study, there are a number of lines of evidence that suggest that this adjustment in the operating point of the baroreflex is not likely to be primarily responsible for orthostatic hypotension, though there may be indirect effects that contribute in part to this multifactorial syndrome. First, as noted above, the heart rate response to upright posture appears to be preserved, possibly by augmented sympathetic activity after vagal withdrawal has been complete. This requirement for increased sympathetic activity to increase heart rate may however contribute to stimulation of cardiac afferents in a small, relatively empty heart, and may facilitate the elaboration of a fainting reflex (32) . Second, although plasma volume restoration with Dextran normalized the decreased baseline spontaneous baroreflex function after bed rest, previous studies have failed to normalize orthostatic tolerance after bed rest by saline infusion (3, 4) , though it could be argued that the magnitude of plasma volume restoration was not as precise or sustained as was accomplished in this study.
Nevertheless, one preliminary report from these same subjects showed that post bed rest orthostatic intolerance was minimally affected even by infusion of Dextran adjusted to plasma volume and cardiac filling pressure (23) . We speculate that factors related to cardiovascular remodeling during bed rest, other than reduced arterial-cardiac baroreflex function by reduced plasma volume, may be primarily responsible for the orthostatic hypotension after space flight or bed rest (19, 20) .
CONCLUSIONS
The present study confirmed that chronic head-down-tilt bed rest leads to reductions in the vagally mediated spontaneous arterial-cardiac baroreflex function and the ability of the baroreflex to modify systemic flow (heart rate x stroke volume; effective gain). However those abnormalities in baroreflex control were completely normalized by plasma volume restoration. Hence, the present results provide confirmatory evidence that reductions in plasma volume may be largely responsible for the reduced spontaneous arterial-cardiac baroreflex function after bed rest. LFRR, power in low frequency; HFR-R, power in high frequency of R-R variability;
LF/HFR-R, the ratio of low to high frequency power of R-R interval variability ; LFBP, power in low frequency of blood pressure; HFBP, power in high frequency of blood pressure variability.; NormLFRR, normalized power in low frequency; NormHFRR, normalized power in high frequency of R-R variability; * P<0.05 compared with the levels before bed rest (Pre-bedrest). 
